Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
Looking At BioNTech's Recent Unusual Options Activity
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 62% bearish. Among these notable ...
Deutsche Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
Morgan Stanley Sticks to Its Buy Rating for BioNTech SE (BNTX)
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions
CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...
Nasdaq3d
Looking At BioNTech's Recent Unusual Options Activity
Deep-pocketed investors have adopted a bearish approach towards BioNTech (NASDAQ:BNTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
CureVac stock rises on positive patent ruling against BioNTech
Shares of CureVac (NASDAQ: CVAC) climbed 11% following a favorable patent validity decision in its legal proceedings against BioNTech (NASDAQ: NASDAQ: BNTX). The ...
Pfizer drops after report on U.S. probe related to its COVID vaccine success
Pfizer (PFE) stock drops as company faces a federal probe on claims of delaying 2020 Covid vaccine success announcement for ...